Probiotics and human lactational mastitis: A scoping review
| Autor: | Micah D J Peters, Mary Steen, Pamela Adelson, Melissa Barker |
|---|---|
| Přispěvatelé: | Barker, Melissa, Adelson, Pamela, Peters, Micah DJ, Steen, Mary |
| Rok vydání: | 2020 |
| Předmět: |
Adult
medicine.medical_specialty Anti-Inflammatory Agents Breastfeeding Mastitis 03 medical and health sciences 0302 clinical medicine Power calculations Maternity and Midwifery microbiota medicine Humans Lactation maternity care Intensive care medicine 030219 obstetrics & reproductive medicine 030504 nursing business.industry Incidence Probiotics Obstetrics and Gynecology medicine.disease Checklist lactobacillus Breast Feeding Treatment Outcome Systematic review breast feeding Baseline characteristics breast milk Female Abstract problem 0305 other medical science business Breast feeding |
| Zdroj: | Women and Birth. 33:e483-e491 |
| ISSN: | 1871-5192 |
| DOI: | 10.1016/j.wombi.2020.01.001 |
| Popis: | Problem Lactational mastitis is a common condition amongst breastfeeding women. It is associated with decreased breastfeeding rates and often treated with antibiotics. Background The anti-inflammatory effects of probiotics have been identified as a potential treatment or prevention strategy for lactational mastitis leading to increased commercial and public interest. Despite the marketing of probiotics to women, evidence is still emerging as to its efficacy. Aim/Methods This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) to identify and examine the evidence around probiotic consumption and lactational mastitis. The review addressed the question; what is the evidence regarding probiotic consumption and human lactational mastitis? Studies were critically appraised using the Joanna Briggs Institute checklist for randomised control trials (RCTs). Findings Five RCTs met the inclusion criteria; three concerned probiotic consumption for the treatment of mastitis, two for the prevention of mastitis. All reported a lower incidence of mastitis in the probiotic groups. Discussion Although potentially promising results were reported across all studies there were significant methodological limitations concerning; appropriately described baseline characteristics, study hypotheses, lack of power calculations, definitional issues, and potential conflicts of interest. Conclusion Probiotics may have utility for the treatment or prevention of lactational mastitis. However only a few studies with significant limitations have been published to date. Well designed and conducted studies are needed before evidence-based recommendations can be made for use of probiotics in the treatment or prevention of lactational mastitis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect